Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,783 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,601 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00959647 | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study | completed | Phase 2 | 19 | Genentech, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT04835142 | Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC | completed | Phase 3 | 688 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.INDUSTRY | 1 | May 8, 2026 |
| clinicaltrials |
| NCT04864067 | No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer(NOAHS-ARC) | completed | Phase 2 | 39 | Servicio de Salud Metropolitano Sur OrienteOTHER_GOV | 1 | May 8, 2026 | clinicaltrials |
| NCT06204497 | The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients | completed | N/A | 570 | Sir Run Run Shaw HospitalOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03552718 | QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. | completed | Phase 1 | 5 | NantBioScience, Inc.INDUSTRY | 1 | May 7, 2026 | clinicaltrials |
| NCT06189846 | Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer(LUMEVAL) | completed | — | 82 | Bordeaux Colorectal Institute AcademyOTHER | 5 | May 7, 2026 | clinicaltrials |
| NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | completed | Phase 2 | 58 | University of Texas Southwestern Medical CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04223141 | Single-stapled Double Purse-string Technique for Colorectal Anastomosis | completed | N/A | 39 | Vejle HospitalOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04726319 | Family History App in Personalized Medicine(FHAMe) | completed | N/A | 627 | University of TorontoOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT03336658 | Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer(ITB) | completed | — | 150 | Insel Gruppe AG, University Hospital BernOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03797326 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | completed | Phase 2 | 611 | Merck Sharp & Dohme LLCINDUSTRY | 17 | May 4, 2026 | clinicaltrials |
| NCT06152276 | SafeHeal Diverting Ileostomy Pivotal Study(SH-SOC23) | completed | — | 132 | SafeHeal IncINDUSTRY | 4 | May 4, 2026 | clinicaltrials |
| NCT02837263 | PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer | completed | Phase 1 | 15 | University of Wisconsin, MadisonOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT05180565 | Safe Anastomosis Feasibility Study(SAFE2019) | completed | N/A | 27 | SafeHeal IncINDUSTRY | 2 | May 1, 2026 | clinicaltrials |
| NCT07563166 | Clinicopathologic Features and Staging Risk Factors of Early-Onset Colorectal Cancer | completed | — | 500 | Run-hua LiOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT05004350 | A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.(NAUTICALCRC) | completed | Phase 2 | 107 | Pierre Fabre MedicamentINDUSTRY | 1 | Apr 30, 2026 | clinicaltrials |
| NCT06212128 | RAPIDO vs LCRT vs Upfront Surgery - a Prospective Cohort Study(RAPIDO) | completed | — | 57 | Sengkang General HospitalOTHER | 0 | Apr 30, 2026 | clinicaltrials |
| NCT06866678 | Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery | completed | — | 200 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07024537 | FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial(HAIC，CRLM) | completed | Phase 2 | 44 | Meng QiuOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT04558398 | Impact of Exercise on Mitochondria in Cancer Patients.(ICCE-Mito) | completed | N/A | 15 | University of NottinghamOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT02299596 | Physical Activity in Relation to Surgical Procedures | completed | N/A | 761 | Sahlgrenska University HospitalOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06428487 | Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer | completed | Phase 2 | 30 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT00819208 | Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer(CHALLENGE) | completed | N/A | 889 | Canadian Cancer Trials GroupNETWORK | 6 | Apr 24, 2026 | clinicaltrials |
| NCT04868773 | Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy | completed | Phase 1 | 15 | University of California, IrvineOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT01787500 | Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | completed | Phase 1 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03981146 | A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer(ANICCA) | completed | Phase 2 | 35 | University of BirminghamOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05414448 | Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection(AIDEN) | completed | N/A | 1,726 | Chinese University of Hong KongOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT02584985 | Evaluate Efficacy, Morbidity and Functional Outcome of Endoscopic TranAnal Proctectomy vs Standard Transabdominal Laparoscopic Proctectomy for Rectal Cancer(ETAP) | completed | Phase 3 | 226 | Institut Paoli-CalmettesOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT03965325 | FOcUs on Colorectal CAncer oUtcomes: Long-Term Study(Foucault) | completed | — | 133 | IHU StrasbourgOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05195970 | Walnuts and Colon Health | completed | N/A | 140 | UConn HealthOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT02110329 | Simultaneaous Detection of Quantitative Somatic Alterations Using the Qantitative Multiplex Pcr of Short Fluorescent Fragments Method (QMPSF) in Stage II-III Colon Cancer: a Prospective Study(Code Barre) | completed | N/A | 401 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT02557061 | Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers(TIL) | completed | N/A | 56 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT02872779 | Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer(COCA-MACS) | completed | N/A | 74 | University Hospital, RouenOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04355156 | Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer(AXMUS-C) | completed | Phase 2 | 52 | Imperial College LondonOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT03935282 | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors(AH-HA) | completed | N/A | 645 | Wake Forest University Health SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT04610086 | Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study(CyDESA) | completed | — | 846 | Corporacion Parc TauliOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01822444 | ANGIOPREDICT. ICORG 12-16, V3 | completed | — | 76 | Cancer Trials IrelandNETWORK | 2 | Apr 13, 2026 | clinicaltrials |
| NCT03699111 | Identification of New Patient Stratification Tools in MSS RAS mt mCRC(COLOSSUS) | completed | — | 29 | Cancer Trials IrelandNETWORK | 3 | Apr 13, 2026 | clinicaltrials |
| NCT04544852 | Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer | completed | N/A | 60 | National University Health System, SingaporeOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06791395 | Real-time AI-assisted Endocyroscopy for the Diagnosis of Colorectal Lesions | completed | — | 570 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07526090 | Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong | completed | — | 500 | Qianfoshan HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | completed | Phase 2 | 58 | Canadian Cancer Trials GroupNETWORK | 2 | Apr 9, 2026 | clinicaltrials |
| NCT06549803 | Comparison of Method for Skin Closure in Colorectal Cancer. | completed | N/A | 304 | Yoon Suk LeeOTHER | 1 | Apr 9, 2026 | clinicaltrials |
| NCT04081779 | Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study | completed | N/A | 261 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT06973161 | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors | completed | — | 140 | AstraZenecaINDUSTRY | 12 | Apr 8, 2026 | clinicaltrials |
| NCT07517848 | Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study | completed | N/A | 198 | Manisa Celal Bayar UniversityOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT03550885 | Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk | completed | N/A | 15 | University of Illinois at ChicagoOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06048146 | A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis | completed | N/A | 180 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07512726 | DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer | completed | N/A | 24 | Ilknur YaziciogluOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT02343601 | Perioperative Hemodynamic Optimization Using the Photoplethysmography in Colorectal Surgery(PANEX3) | completed | Phase 3 | 160 | University Hospital, CaenOTHER | 1 | Apr 2, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2026source: clinicaltrials